Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia

Detalles Bibliográficos
Autores principales: Wang, Huafeng, Yang, Chang, Shi, Ting, Zhang, Yi, Qian, Jiejing, Wang, Yungui, Hu, Yongxian, Mao, Liping, Ye, Xiujin, Liu, Fang, Xi, Zhenfang, Shou, Lihong, Fu, Caiyun, Naranmandura, Hua, Jin, Jie, Zhu, Hong-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799711/
https://www.ncbi.nlm.nih.gov/pubmed/35091541
http://dx.doi.org/10.1038/s41408-022-00621-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799711/
https://www.ncbi.nlm.nih.gov/pubmed/35091541
http://dx.doi.org/10.1038/s41408-022-00621-9

Ejemplares similares